RayKnowChina Research Map
Shortlist

RecruitingGliomaPhase not stated

Registered title, quoted from ClinicalTrials.gov

Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

An open trial on glioma, registered on ClinicalTrials.gov. Led by Children's Hospital, Zhejiang University School of Medicine; 0 other hospitals on this site are listed as study sites.

Status, phase and start date as registered on ClinicalTrials.gov on 18 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.

The study team’s contact details are on the registry record. This site does not pass on enquiries.

Hospitals in mainland China listed for this trial 1

Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.

  1. Lead sponsorChildren's Hospital, Zhejiang University School of Medicine浙江大学医学院附属儿童医院HangzhouHospital page

The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov

Source: ClinicalTrials.gov record NCT07450872, read on 18 Nov 2026; hospital names matched to this site’s hospital list. How names are matched

Checklist for this trial 1

Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.

Show the checklist (1 points)Hide the checklist
  1. 8 years to 18 years; sex: all

    Registered eligibility fields

Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; stage or severity, as the trial defines it; earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes; pregnancy, breastfeeding and contraception.

Questions to ask the study team

Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT07450872, read on 10 Nov 2026.

Registered criteria

Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.

Inclusion Criteria for Children:

  • Aged 8-18 years;
  • Clinically and pathologically confirmed diagnosis of cancer (including leukemia, lymphoma, central nervous system tumors, or other common solid tumors);
  • Currently in the rehabilitation/maintenance phase or completed treatment ≥6 months prior to enrollment;
  • No cognitive impairment; able to understand, communicate, and complete questionnaires independently;
  • Written informed consent/assent obtained from participants and their legal guardians.

Exclusion Criteria for Children:

  • Presence of severe treatment-related sequelae (e.g., significant organ dysfunction or neurological impairment) that may interfere with symptom assessment;
  • Poor compliance or inability to independently complete interviews/questionnaires;
  • Concurrent participation in other interventional clinical trials that may influence study outcomes;
  • Planned major surgery or initiation of new chemotherapy/radiotherapy during the study period.

Inclusion Criteria for Caregivers:

  • Primary caregiver of an eligible CCS participant;
  • Aged ≥20 years;
  • Able to understand study content and complete questionnaires, with adequate literacy and communication ability;
  • Written informed consent provided prior to participation.

Exclusion Criteria for Caregivers:

  • Experience of major adverse life events within the past 6 months (e.g., bereavement, divorce) that may affect psychological assessment
  • Presence of severe cognitive impairment;
  • Presence of severe aphasia, psychiatric disorders, or other conditions preventing independent completion of assessments.

Quoted from ClinicalTrials.gov, NCT07450872, participation criteria. Read on 10 Nov 2026.

Where this information comes from

The registry record

ClinicalTrials.gov (US National Library of Medicine), record NCT07450872, read on 18 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.

Diseases and hospitals

The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions

What is left out

Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.

Suggest a correctionClinicalTrials.gov NCT07450872